ornithine and Cancer of Prostate

ornithine has been researched along with Cancer of Prostate in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-199010 (66.67)18.7374
1990's0 (0.00)18.2507
2000's2 (13.33)29.6817
2010's1 (6.67)24.3611
2020's2 (13.33)2.80

Authors

AuthorsStudies
Antognelli, C; Frosini, R; Macchioni, L; Marinucci, L; Talesa, VN1
Chen, S; Cheng, LL; Grant, A; Habbel, P; Li, B; Malloy, C; Mason, RP; Nowak, J; Vandergrift, LA; Wang, N; Wang, Y; Zhu, M1
Antognelli, C; Cecchetti, R; Peirce, MJ; Riuzzi, F; Talesa, VN1
Diegelman, P; Kee, K; Kisiel, N; Kramer, DL; Merali, S; Porter, CW; Powell, CT; Vujcic, S1
Balis, ME; Dunzendorfer, U; Kleinert, E; Relyea, NM; Whitmore, WF1
Herr, HW; Kleinert, EL; Relyea, NM; Whitmore, WF1
Covey, DF; Fair, WR; Heston, WD; Kadmon, D1
Balis, ME; Dunzendorfer, U; Fogh, J; Releyea, N; Whitmore, WF1
Herr, HW; Kleinert, EL1
Fair, WR; Heston, WD; Lazan, DW1
Fair, WR; Heston, WD; Kadmon, D; Lazan, DW1
McQuarrie, SA; Srinath, P; Suresh, MR1
Dunzendorfer, U; Knöner, M1
Covey, DF; Fair, WR; Heston, WD; Uy, L1
Dunzendorfer, U1

Other Studies

15 other study(ies) available for ornithine and Cancer of Prostate

ArticleYear
Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases.
    International journal of molecular sciences, 2021, Sep-22, Volume: 22, Issue:19

    Topics: Antigens, Neoplasm; Bone and Bones; Bone Neoplasms; Cell Dedifferentiation; Cell Line, Tumor; Cell Movement; Culture Media, Conditioned; Humans; Imidazoles; Male; Mitogen-Activated Protein Kinases; Ornithine; Osteoblasts; PC-3 Cells; Prostate; Prostatic Neoplasms; Reactive Oxygen Species

2021
    NMR in biomedicine, 2023, Volume: 36, Issue:8

    Topics: Animals; Humans; Male; Ornithine; Polyamines; Prostate; Prostatic Neoplasms; Rats; Spermine

2023
Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control.
    Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:5

    Topics: 3' Untranslated Regions; Aged; Base Sequence; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Homoarginine; Humans; Imidazoles; Lactoylglutathione Lyase; Male; Metformin; MicroRNAs; Middle Aged; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Ornithine; Phenotype; Prostatic Neoplasms; Pyrimidines; Signal Transduction; Smad Proteins; Thiolester Hydrolases; Transforming Growth Factor beta1

2018
Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells.
    The Journal of biological chemistry, 2004, Jun-25, Volume: 279, Issue:26

    Topics: Acetyl Coenzyme A; Acetyltransferases; Adenosylmethionine Decarboxylase; Carcinoma; Cell Division; Deoxyadenosines; Eflornithine; Enzyme Inhibitors; Humans; Male; Methionine; Ornithine; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Polyamines; Prostatic Neoplasms; Putrescine; RNA, Messenger; S-Adenosylmethionine; Tetracyclines; Thionucleosides; Tumor Cells, Cultured

2004
Antigrowth effect of some inhibitors of polyamine synthesis on transplantable prostate cancer.
    Oncology, 1983, Volume: 40, Issue:1

    Topics: Animals; Body Weight; Drug Therapy, Combination; Eflornithine; Guanidines; Male; Mitoguazone; Neoplasm Transplantation; Neoplasms, Experimental; Ornithine; Polyamines; Prostatic Neoplasms; Rats; Vidarabine

1983
Potentiation of methylglyoxal-bis-guanylhydrazone by alpha-difluoromethylornithine in rat prostate cancer.
    Cancer, 1984, Mar-15, Volume: 53, Issue:6

    Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Line; Drug Synergism; Eflornithine; Guanidines; Humans; Male; Mitoguazone; Neoplasm Transplantation; Ornithine; Prostatic Neoplasms; Rats; Rats, Inbred Strains

1984
Differential effect of alpha-difluoromethylornithine on the in vivo uptake of 14C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor.
    Cancer research, 1984, Volume: 44, Issue:3

    Topics: Animals; Antineoplastic Agents; Biological Transport; Carbon Radioisotopes; Cells, Cultured; Eflornithine; Guanidines; Male; Mitoguazone; Ornithine; Polyamines; Prostatic Neoplasms; Putrescine; Rats; Rats, Inbred Strains; Spermidine

1984
Some effects of inhibitors of polyamine synthesis on experimental prostatic cancer.
    Arzneimittel-Forschung, 1984, Volume: 34, Issue:1

    Topics: Adenine; Adenocarcinoma; Adenosylmethionine Decarboxylase; Animals; Carboxy-Lyases; Eflornithine; Guanidines; Male; Mice; Mice, Nude; Mitoguazone; Ornithine; Ornithine Decarboxylase Inhibitors; Polyamines; Prostatic Neoplasms; Rats; Vidarabine

1984
Antigrowth effect of polyamine biosynthesis inhibitors on the Dunning R 3327-G prostatic tumor.
    The Prostate, 1984, Volume: 5, Issue:4

    Topics: Adenocarcinoma; Animals; Body Weight; Cell Division; Drug Therapy, Combination; Eflornithine; Guanidines; Male; Mitoguazone; Ornithine; Polyamines; Prostatic Neoplasms; Rats; Rats, Inbred Strains

1984
Aminoguanidine reversal of the inhibitory effects of ornithine analogs on the in vitro clonogenic survival of the R3327AT prostate-derived tumor.
    Cancer letters, 1981, Volume: 11, Issue:4

    Topics: Amine Oxidase (Copper-Containing); Animals; Carboxy-Lyases; Cell Line; Eflornithine; Guanidines; Male; Ornithine; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Prostatic Neoplasms; Putrescine; Rats

1981
Copenhagen rat prostatic tumor ornithine decarboxylase activity (ODC) and the effect of the ODC inhibitor alpha-difluoromethylornithine.
    The Prostate, 1982, Volume: 3, Issue:4

    Topics: Animals; Antineoplastic Agents; Carboxy-Lyases; Cell Line; Eflornithine; Male; Neoplasms, Experimental; Ornithine; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Prostatic Neoplasms; Rats; Rats, Inbred Strains

1982
Comparative uptake of polyamines by prostate and non-prostate cancer cell lines.
    Nuclear medicine and biology, 2002, Volume: 29, Issue:4

    Topics: Animals; Breast Neoplasms; Carbon Radioisotopes; Humans; Male; Ornithine; Polyamines; Prostatic Neoplasms; Putrescine; Radionuclide Imaging; Rats; Reproducibility of Results; Sensitivity and Specificity; Spermidine; Spermine; Tumor Cells, Cultured; Urogenital Neoplasms

2002
[Therapy with inhibitors of polyamine biosynthesis in refractory prostatic carcinoma. An experimental and clinical study].
    Onkologie, 1985, Volume: 8, Issue:4

    Topics: Adenocarcinoma; Adenosylmethionine Decarboxylase; Animals; Antineoplastic Agents; Carboxy-Lyases; Carcinoma; Eflornithine; Estrogens; Humans; Male; Mitoguazone; Neoplasm Metastasis; Ornithine; Ornithine Decarboxylase Inhibitors; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatitis; Putrescine; Rats; Spermidine; Spermine

1985
Cytotoxic activity of aziridinyl putrescine enhanced by polyamine depletion with alpha-difluoromethylornithine.
    Biochemical pharmacology, 1985, Jul-01, Volume: 34, Issue:13

    Topics: Antineoplastic Agents; Cell Line; Eflornithine; Humans; Male; Ornithine; Polyamines; Prostatic Neoplasms; Putrescine

1985
[Polyamines, polyamine antimetabolites and urogenital tumors. State of research and clinical results].
    Urologia internationalis, 1985, Volume: 40, Issue:5

    Topics: Adenosylmethionine Decarboxylase; Antimetabolites, Antineoplastic; Carboxy-Lyases; Drug Combinations; Eflornithine; Enzyme Induction; Enzyme Inhibitors; Humans; Kidney Neoplasms; Male; Mitoguazone; Ornithine; Polyamines; Prostatic Neoplasms; Urogenital Neoplasms

1985